Management of children with hypercholesterolemia;Prise en charge des hypercholestérolémies de l'enfant

Archives de Pediatrie

Volumn 13, Issue 1, 2006, Pages 104-110

  Girardet, J P ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Children; Family hypercholesterolemia; HMG CoA reductase inhibitors; Hypercholesterolemia; Plant sterols

Indexed keywords

ATORVASTATIN; COLESTYRAMINE; EZETIMIBE; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

ATHEROSCLEROSIS; AUTOSOMAL DOMINANT INHERITANCE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DYSLIPIDEMIA; FAMILY HISTORY; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; PREMATURITY; REVIEW; TREATMENT PLANNING;

EID: 30144432965     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2005.09.020     Document Type: Article

References (36)

1. La prise en charge thérapeutique du patient dyslipidémique. Agence française de sécurité sanitaire des produits de santé (Afssaps) 2000 ; http:/agmed.sante.gouv.fr
2. Scientific steering committee on behalf of the Simon Broome register group Mortality in treated heterozygous familial hypercholesterolemia: Implication for clinical management Atherosclerosis 142 1999 105 112
3. C. Barnerias, S. Viola, A. Morali, F. Lacaille, C. Maurage, and J.-P. Girardet L'hyperlipid́mie familiale combińe:: expression ph́notypique chez l'enfant et risque vasculaire assocí Arch. Pediatr. 9 2002 982
4. A. Tybjaerg-Hansen, R. Steffensen, and H. Meinertz Association of mutations in the apolipoprotein B100 gene with hypercholesterolemia and the risk of ischemic heart disease N. Engl. J. Med. 338 1998 1577 1584
5. J.L. Goldstein, H.H. Hobbs, and M.S. Brown Familial hypercholesterolemia C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The metabolic basis of inherited disease 2001 Mc Graw - Hill New York 2863 2913
6. J. Rodenburg, M.N. Vissers, and A. Wiegman Familial hypercholesterolemia in children Curr. Opin. Lipidol. 15 2004 405 411
7. F. Civeira Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia Atherosclerosis 173 2004 55 68
8. A. Wiegman, J. Rodenburg, and S. De Jongh Family history and cardiovascular risk in familial hypercholesterolemia. Data in more than 1000 children Circulation 107 2003 1473 1478
9. S. Viola, P. Benlian, and P. Morali Apolipoprotein B Arg3500Gln mutation prevalence in children with known hypercholesterolemia. A french multicenter study J. Pediatr. Gastroenterol. Nutr. 33 2001 122 126
10. B. Saint-Jorre, M. Varret, and C. Dachet Autosomal dominant type IIa hypercholesterolemia: Evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects Eur. J. Hum. Genet. 8 2000 621 630
11. Allard D, Amsellem S, Abifadel M, et al. Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia. Human Mutation 2005 (à paraître).
12. J.A. Cortner, P.M. Coates, and P.R. Gallagher Prevalence and expression of familial combined hyperlipidemia in childhood J. Pediatr. 116 1990 514 519
13. G.S. Berenson, S.T. Srinivasan, W. Bao, W.P. Newman, R.E. Tracy, W.A. Wattigney for the Bogalusa Heart Study. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults N. Engl. J. Med. 338 1998 1650 1656
14. Y. Aggoun, D. Bonnet, and D. Sidi Arterial mechanical changes in children with familial hypercholesterolemia Arterioscler. Thromb. Vasc. Biol. 20 2000 2070 2075
15. A. Wiegman, E. De Groot, and B.A. Hutten Arterial intima-media thickness in children heterozygous for familial hypercholesterolemia Lancet 363 2004 369 370
16. S. De Jongh, M.R. Lilien, and H.D. Bakker Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia Atherosclerosis 163 2002 193 197
17. M.J. Järvisalo, L. Jartti, and K. Nänto-Salonen Increased aortic intima-media thickness. A marker of preclinical atherosclerosis in high-risk children Circulation 104 2001 2943 2947
18. J.P. Girardet, L. Sanchez, S. Amsellem, and P. Benlian Clinical and biological predictors for dominantly inherited hypercholesterolemia in children. Validation by molecular genetics J. Pediatr. Gastroenterol. Nutr. 39 suppl 1 2004 S123
19. National Cholesterol Education Program Report of the expert panel on blood cholesterol levels in children and adolescents Pediatrics 89 1992 525 584
20. Socít́ fraņaise de ṕdiatrie - Comit́ de nutrition Contrôle dít́tique de la cholest́roĺ mie et pŕvention de l'ath́rome Arch. Fr. Pediatr. 44 1987 211 217
21. ESPGAN Committee on Nutrition Committee report: Childhood diet and prevention of coronary heart disease J. Pediatr. Gastroenterol. Nutr. 19 1994 161 169
22. Agence fraņaise de ścurit́ sanitaire des aliments (Afssa) Guide de nutrition des enfants et ados pour tous les parents. Livret d'accompagnement destiń aux professionnels de sant́ 2004 INPES Paris 106 109
23. J. Sheperd, S.M. Cobbe, and I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N. Engl. Med. 333 1995 1301 1307
24. S. De Jongh, M.R. Lilien, and J. Op't Roodt Early statin therapy restores endothelial function in children with familial hypercholesterolemia J. Am. Coll. Cardiol. 40 2002 2117 2121
25. A. Wiegman, B.A. Hutten, and E. De Groot Efficacy and safety of statin therapy in children with familial hypercholesterolemia: A randomized controlled trial JAMA 292 2004 331 337
26. B. Koletzko, and M. Herzog Hyperlipidemia in children and adolescents: Diagnosis and therapy Schweiz. Med. Wochenschr. 128 1998 477 485
27. C.J. Glueck, M.J. Mellies, and M. Dine Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia Pediatrics 78 1986 338 348
28. S. Tonstad, J. Knudtzon, and M. Sivertsen Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia J. Pediatr. 129 1996 42 49
29. B.W. McCrindle, L. Ose, and D. Maaris Efficacy and safety of atorvastatin in children and adolescents with familial hyper cholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled study J. Pediatr. 142 2003 74 80
30. S. De Jongh, L. Ose, and T. Szamosi Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double blind, placebo-controlled trial with simvastatin Circulation 106 2002 2231 2237
31. C. Gagń, H.E. Bays, and S.R. Weiss Efficacy and safety of Ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia Am. J. Cardiol. 90 2002 1084 1091
32. K.C. Maki, M.H. Davidson, and D.M. Umporowicz Lipid responses to plant-sterol-enriched reduced fat-spreads incorporated into a National Cholesterol Education Program step 1 diet Am. J. Clin. Nutr. 74 2001 33 43
33. A.L. Amundsen, L. Ose, M.S. Nenseter, and F.Y. Ntanios Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia Am. J. Clin. Nutr. 76 2002 338 344
34. S. De Jongh, M.N. Vissers, and P. Rol Plant sterols lower LDL Cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolemia J. Inherit. Metab. Dis. 26 2003 343 351
35. M. Mietu-Snyder, and M.J. Malloy Endothelial dysfunction occurs with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy J. Pediatr. 133 1998 35 40
36. D. Marks, D. Wonderling, and M. Thorogood Screening for hypercholesterolemia versus case finding for familial hypercholesterolemia: a systematic review and cost-effectiveness analysis Health Technol. Assess. 4 2000 1 123